GlassScriptPhysician profile
Steven Dookie
NPI 1164256640
$1,059.93
in general payments reported to CMS, 2019-2025
15 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $196.57 | 2025 | |
| Abbvie INC. | $187.19 | 2025 | |
| Axsome Therapeutics, INC. | $165.76 | 2025 | Symbravo |
| Alkermes, INC. | $124.39 | 2025 | Lybalvi |
| Gilead Sciences, INC. | $77.36 | 2025 | |
| Glaxosmithkline, LLC. | $51.82 | 2025 | Trelegy Ellipta |
| Novo Nordisk INC | $49.13 | 2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.96 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.87 | 2025 | Xifaxan |
| Vertex Pharmaceuticals Incorporated | $32.55 | 2025 | |
| Indivior INC. | $23.66 | 2025 | Sublocade |
| Renalytix Ai, INC. | $23.47 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Ani Pharmaceuticals, INC. | $18.23 | 2025 | Purified Cortrophin Gel |
| Sumitomo Pharma America, INC. | $16.85 | 2025 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $16.12 | 2025 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Dookie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.